Felix Steger

621 total citations
14 papers, 176 citations indexed

About

Felix Steger is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Felix Steger has authored 14 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Felix Steger's work include Lung Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Felix Steger is often cited by papers focused on Lung Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Felix Steger collaborates with scholars based in Germany and Austria. Felix Steger's co-authors include Oliver Kölbl, Matthias Hautmann, Christoph Süß, Ulrich Neumaier, Petros Christopoulos, W. Brückl, Stephan Eisenmann, Franz Josef Putz, Christian Schumann and Martin Faehling and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and BMC Cancer.

In The Last Decade

Felix Steger

14 papers receiving 176 citations

Peers

Felix Steger
A. Stainier Belgium
Luis Tamara United States
Umesh Parampalli United Kingdom
Kim Taubman Australia
Felix Steger
Citations per year, relative to Felix Steger Felix Steger (= 1×) peers Henrik Kjölhede

Countries citing papers authored by Felix Steger

Since Specialization
Citations

This map shows the geographic impact of Felix Steger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Steger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Steger more than expected).

Fields of papers citing papers by Felix Steger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Steger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Steger. The network helps show where Felix Steger may publish in the future.

Co-authorship network of co-authors of Felix Steger

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Steger. A scholar is included among the top collaborators of Felix Steger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Steger. Felix Steger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Tamaskovics, Bálint, Markus Hecht, Philipp Schubert, et al.. (2023). 944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial. Annals of Oncology. 34. S593–S593. 1 indexed citations
3.
Faehling, Martin, Christian Schumann, Petra Hoffknecht, et al.. (2020). 1244P Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP). Annals of Oncology. 31. S806–S807. 1 indexed citations
5.
Faehling, Martin, Christian Schumann, Petros Christopoulos, et al.. (2020). Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP. SHILAP Revista de lepidopterología. 34. 106556–106556. 3 indexed citations
6.
Hautmann, Matthias, Lukas Philipp Beyer, Matthias Hipp, et al.. (2019). Re-irradiation for humeral epicondylitis. Strahlentherapie und Onkologie. 196(3). 262–269. 5 indexed citations
7.
Hautmann, Matthias, Matthias Hipp, Ulrich Neumaier, et al.. (2019). Re-irradiation for osteoarthritis—retrospective analysis of 217 joints. Strahlentherapie und Onkologie. 195(12). 1060–1067. 14 indexed citations
8.
Hautmann, Matthias, Matthias Hipp, Ulrich Neumaier, et al.. (2019). Radiotherapy for osteoarthritis of the ankle and tarsal joints—analysis of 66 joints. Strahlentherapie und Onkologie. 196(6). 569–575. 11 indexed citations
9.
Steger, Felix, Matthias Hautmann, Christoph Süß, et al.. (2019). Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline—is the risk of relevant errors overestimated?. Strahlentherapie und Onkologie. 195(12). 1086–1093. 6 indexed citations
10.
Hautmann, Matthias, Ulrich Neumaier, Christoph Süß, et al.. (2019). Radiotherapy for osteoarthritis—an analysis of 295 joints treated with a linear accelerator. Strahlentherapie und Onkologie. 196(8). 715–724. 18 indexed citations
11.
Hautmann, Matthias, Lukas Philipp Beyer, Christoph Süß, et al.. (2018). Radiotherapy of epicondylitis humeri. Strahlentherapie und Onkologie. 195(4). 343–351. 10 indexed citations
12.
Hautmann, Matthias, Ernst‐Michael Jung, Lukas Philipp Beyer, et al.. (2018). Is low dose radiotherapy an effective treatment for Baker’s cyst?. Strahlentherapie und Onkologie. 195(1). 69–76. 8 indexed citations
13.
Steger, Felix, Matthias Hautmann, & Oliver Kölbl. (2012). 5-FU-induced cardiac toxicity - an underestimated problem in radiooncology?. Radiation Oncology. 7(1). 212–212. 27 indexed citations
14.
Steger, Felix, et al.. (1991). Wash-Off Effects in Urban Areas. Radiation Protection Dosimetry. 37(3). 189–194. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026